Ratings by Citi (Yigal Nochomovitz)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/22/2021 | Innate Pharma S.A. | IPHA | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2021 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2021 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2021 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2021 | Caribou Biosciences Inc. | CRBU | New Coverage | Neutral (N/A) |
26.48 (24.24) |
-8.46% | Details | |
| 8/13/2021 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2021 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Neutral (Buy) |
37.92 (21.30) |
-43.83% | Details | |
| 7/23/2021 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Unity Biotechnology Inc | UBX | Upgrade | Buy (Sell) |
4.34 (2.94) |
-32.26% | Details | |
| 6/14/2021 | CRISPR Therapeutics | CRSP | Upgrade | Neutral (Sell) |
123.71 (116.43) |
-5.88% | Details | |
| 6/8/2021 | Harpoon Therapeutics | HARP | Downgrade | Neutral (Buy) |
15.27 (7.96) |
-47.87% | Details | |
| 6/7/2021 | Merus N.V. | MRUS | Upgrade | Buy (Neutral) |
20.68 (22.21) |
7.4% | Details | |
| 6/4/2021 | Mirati Therapeutics | MRTX | Upgrade | Buy (Neutral) |
154.86 (166.36) |
7.43% | Details | |
| 5/26/2021 | Puma Biotechnology | PBYI | Maintain | Neutral (N/A) |
|
Details | ||
| 5/25/2021 | Syndax Pharmaceuticals | SNDX | New Coverage | Buy (N/A) |
17.69 (18.80) |
6.27% | Details | |
| 5/21/2021 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 5/21/2021 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2021 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2021 | Imara Inc. | IMRA | New Coverage | Buy (N/A) |
7.46 (4.20) |
-43.7% | Details | |
| 5/11/2021 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | Ultragenyx Pharma | RARE | Upgrade | Buy (Neutral) |
101.85 (95.11) |
-6.62% | Details | |
| 3/25/2021 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2021 | Ovid Therapeutics Inc | OVID | Maintain | Neutral (N/A) |
|
Details | ||
| 3/2/2021 | Atara Biotherapeutics | ATRA | Upgrade | Buy (Neutral) |
17.10 (17.00) |
-0.58% | Details | |
| 3/1/2021 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Unity Biotechnology Inc | UBX | Downgrade | Sell (Neutral) |
8.28 (2.94) |
-64.49% | Details | |
| 2/11/2021 | Fate Therapeutics | FATE | Downgrade | Neutral (Buy) |
103.31 (64.85) |
-37.23% | Details | |
| 1/28/2021 | Zymeworks | ZYME | Upgrade | Buy (Neutral) |
44.06 (28.52) |
-35.27% | Details | |
| 1/25/2021 | Zymeworks | ZYME | Downgrade | Neutral (Buy) |
52.16 (28.52) |
-45.32% | Details | |
| 1/15/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2021 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2021 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2020 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2020 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2020 | Atara Biotherapeutics | ATRA | Downgrade | Neutral (Buy) |
26.23 (17.10) |
-34.81% | Details | |
| 12/8/2020 | Lexicon Pharmaceuticals | LXRX | Upgrade | Buy (Neutral) |
1.58 (4.94) |
212.66% | Details | |
| 12/7/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2020 | Ovid Therapeutics Inc | OVID | Downgrade | Neutral (Buy) |
6.84 (3.45) |
-49.56% | Details | |
| 11/25/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2020 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2020 | Cellectis | CLLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2020 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2020 | Arcturus Therapeutics | ARCT | New Coverage | Buy (N/A) |
49.97 (50.71) |
1.48% | Details | |
| 9/18/2020 | Mirati Therapeutics | MRTX | Downgrade | Neutral (Buy) |
161.97 (166.36) |
2.71% | Details | |
| 8/19/2020 | Cellectis | CLLS | Upgrade | Buy (Buy) |
17.22 (13.41) |
-22.13% | Details | |
| 8/18/2020 | Unity Biotechnology Inc | UBX | Downgrade | Neutral (Buy) |
12.43 (2.94) |
-76.35% | Details | |
| 8/17/2020 | Imara Inc. | IMRA | Upgrade | Buy (Neutral) |
20.61 (4.20) |
-79.62% | Details | |
| 8/11/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2020 | MacroGenics | MGNX | Downgrade | Neutral (Buy) |
26.75 (19.74) |
-26.21% | Details | |
| 7/13/2020 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Imara Inc. | IMRA | Downgrade | Neutral (Buy) |
34.23 (4.20) |
-87.73% | Details | |
| 6/26/2020 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2020 | Arvinas Inc. | ARVN | Upgrade | Buy (Neutral) |
44.85 (88.61) |
97.57% | Details | |
| 5/8/2020 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2020 | Portola Pharmaceuticals | PTLA | Downgrade | Neutral (Buy) |
7.76 (18.03) |
132.35% | Details | |
| 4/28/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/28/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/23/2020 | Atara Biotherapeutics | ATRA | Upgrade | Buy (Neutral) |
8.00 (17.00) |
112.5% | Details | |
| 4/6/2020 | Imara Inc. | IMRA | New Coverage | Buy (N/A) |
15.75 (4.20) |
-73.33% | Details | |
| 3/31/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/12/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2020 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 3/2/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2020 | Ardelyx, Inc | ARDX | New Coverage | Buy (N/A) |
7.33 (1.31) |
-82.13% | Details | |
| 1/28/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2020 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 1/21/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2020 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 1/13/2020 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2020 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2019 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2019 | Aerie Pharma | AERI | New Coverage | Buy (N/A) |
21.92 (11.79) |
-46.21% | Details | |
| 12/18/2019 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2019 | Galera Therapeutics | GRTX | New Coverage | Buy (N/A) |
12.53 (7.92) |
-36.79% | Details | |
| 11/19/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | Ovid Therapeutics Inc | OVID | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 11/8/2019 | Lexicon Pharmaceuticals | LXRX | Downgrade | Neutral (Buy) |
3.88 (4.94) |
27.32% | Details | |
| 11/7/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 11/7/2019 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2019 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 10/9/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2019 | Ovid Therapeutics Inc | OVID | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2019 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2019 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2019 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2019 | NuCana | NCNA | Maintain | Buy () |
|
Details | ||
| 8/21/2019 | Synlogic Inc. | SYBX | Downgrade | Sell (Buy) |
4.83 (3.17) |
-34.37% | Details | |
| 8/12/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2019 | Atara Biotherapeutics | ATRA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2019 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 7/30/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2019 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2019 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2019 | Eiger BioPharma | EIGR | New Coverage | Buy (N/A) |
10.61 (7.00) |
-34.02% | Details | |
| 6/13/2019 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2019 | Puma Biotechnology | PBYI | Maintain | Neutral (N/A) |
|
Details | ||
| 6/5/2019 | Arvinas Inc. | ARVN | Downgrade | Neutral (Buy) |
20.05 (44.85) |
123.69% | Details | |
| 6/4/2019 | Mirati Therapeutics | MRTX | Upgrade | Buy (Neutral) |
89.20 (166.36) |
86.5% | Details | |
| 6/4/2019 | Atara Biotherapeutics | ATRA | Upgrade | Neutral (Sell) |
22.21 (17.00) |
-23.46% | Details | |
| 5/24/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2019 | Cellectis | CLLS | New Coverage | Neutral (N/A) |
18.34 (13.41) |
-26.88% | Details | |
| 5/24/2019 | Acceleron Pharma | XLRN | New Coverage | Buy (N/A) |
43.25 (167.65) |
287.63% | Details | |
| 5/24/2019 | Arcus Biosciences | RCUS | New Coverage | Buy (N/A) |
9.52 (35.97) |
277.84% | Details | |
| 5/15/2019 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2019 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/10/2019 | Puma Biotechnology | PBYI | Downgrade | Neutral (Buy) |
30.02 (6.82) |
-77.28% | Details | |
| 5/2/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/21/2019 | Merus N.V. | MRUS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/20/2019 | Akebia Therapeutics | AKBA | New Coverage | Neutral (N/A) |
8.17 (2.86) |
-64.99% | Details | |
| 3/15/2019 | Merus N.V. | MRUS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/15/2019 | Ovid Therapeutics Inc | OVID | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2019 | Chimerix | CMRX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2019 | Mirati Therapeutics | MRTX | Downgrade | Neutral (Buy) |
72.80 (89.20) |
22.53% | Details | |
| 3/1/2019 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2019 | MacroGenics | MGNX | Upgrade | Buy (Sell) |
11.11 (19.74) |
77.68% | Details | |
| 2/4/2019 | MacroGenics | MGNX | Downgrade | Sell (Neutral) |
11.73 (11.11) |
-5.29% | Details | |
| 1/24/2019 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2019 | CRISPR Therapeutics | CRSP | Downgrade | Sell (Neutral) |
37.13 (116.43) |
213.57% | Details | |
| 1/18/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2019 | Merus N.V. | MRUS | Maintain | Neutral (N/A) |
|
Details | ||
| 12/6/2018 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2018 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2018 | Aldeyra Therapeutics | ALDX | New Coverage | Buy (N/A) |
8.97 (8.50) |
-5.24% | Details | |
| 11/27/2018 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2018 | LOXO | Maintain | Buy (N/A) |
|
Details | |||
| 11/16/2018 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2018 | ProQR Therapeutics N.V. | PRQR | New Coverage | Buy (N/A) |
18.67 (7.79) |
-58.28% | Details | |
| 11/9/2018 | Chimerix | CMRX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/8/2018 | Ultragenyx Pharma | RARE | Upgrade | Neutral (Sell) |
54.34 (95.11) |
75.03% | Details | |
| 11/7/2018 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2018 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2018 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2018 | Ultragenyx Pharma | RARE | Maintain | Sell (N/A) |
|
Details | ||
| 10/22/2018 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
15.56 (20.05) |
28.86% | Details | |
| 9/28/2018 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2018 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2018 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2018 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2018 | Rigel Pharmaceuticals | RIGL | New Coverage | Buy (N/A) |
2.80 (3.74) |
33.57% | Details | |
| 8/24/2018 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 8/24/2018 | Synlogic Inc. | SYBX | Upgrade | Buy (Neutral) |
7.91 (4.83) |
-38.94% | Details |
